Additional file 4 of M2 macrophage-secreted KYNU promotes stemness remodeling and malignant behavior in endometrial cancer via the SOD2-mtROS-ERO1α-UPRER axis

Supplementary Material 4: Table S1. The sequences of primers used for qRT‒PCR and the binding sites in the promoter region of KYNU. Table S2. Information of the primary antibodies used in this study. Table S3. The plasmid sequences used in cell transfection. Table S4. Relationship of SOD2 expression with the clinical characteristics of patients with endometrial cancer. Pearson tests were used for statistical analysis. Table S5. Relationship of ERO1α expression with the clinical characteristics of patients with endometrial cancer. Pearson tests were used for statistical analysis.